Drug
Lauromacrogol
Lauromacrogol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (20.0%)
N/A4 (80.0%)
Trials by Status
unknown240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
Primary Prophylaxis of Gastric Variceal Bleed
NCT02468180
completednot_applicable
Secondary Prophylaxis of Gastric Variceal Bleed
NCT02468206
unknownnot_applicable
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
NCT02468167
completednot_applicable
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
NCT01923064
completedphase_3
ESGVS: Sclerotherapy With Lauromacrogol
NCT00348764
Clinical Trials (5)
Showing 5 of 5 trials
NCT02468180Not Applicable
Primary Prophylaxis of Gastric Variceal Bleed
NCT02468206Not Applicable
Secondary Prophylaxis of Gastric Variceal Bleed
NCT02468167Not Applicable
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
NCT01923064Not Applicable
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
NCT00348764Phase 3
ESGVS: Sclerotherapy With Lauromacrogol
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5